Clinical Trial

A Phase 2 Trial of JKN24011 in COPD

Name: A Phase 2 Trial of JKN24011 in COPD — clinical trial record (NCT07440524)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 2

View on ClinicalTrials.gov →

Record status

This record was last updated February 27, 2026 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.

Summary

A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Efficacy and Safety of Subcutaneous JKN24011 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Trial Details

NCT Number	NCT07440524
Lead Sponsor	Joincare Pharmaceutical Group Industry Co., Ltd
Conditions	COPD (Chronic Obstructive Pulmonary Disease)
Enrollment	215 participants
Start Date	2024-08-01
Primary Completion	2026-04 (estimated)
Study Completion	2026-05 (estimated)
Updated on ClinicalTrials.gov	2026-02-27